|本期目录/Table of Contents|

[1]余燕婷,王霄剑,张天艳,等.远红外线治疗对特殊人群自体动静脉内瘘成熟的影响[J].医学研究与战创伤救治(原医学研究生学报),2019,21(6):598-602.[doi:10.3969/j.issn.1672-271X.2019.06.010]
 YU Yan-ting,WANG Xiao-Jian,ZHANG Tian-Yan,et al.Effect of far-infrared treatment on maturation of autogenous arteriovenous fistula in special population[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2019,21(6):598-602.[doi:10.3969/j.issn.1672-271X.2019.06.010]
点击复制

远红外线治疗对特殊人群自体动静脉内瘘成熟的影响()

《医学研究与战创伤救治》(原医学研究生学报)[ISSN:1672-271X/CN:32-1713/R]

卷:
第21卷
期数:
2019年6期
页码:
598-602
栏目:
临床研究
出版日期:
2019-11-14

文章信息/Info

Title:
Effect of far-infrared treatment on maturation of autogenous arteriovenous fistula in special population
文章编号:
1672-271X(2019)06-0598-05
作者:
余燕婷 王霄剑 张天艳 刘威 高占辉 刘静 季大玺 汪红英
1.210019 南京,南京医科大学附属明基医院肾脏科;2.超声医学科
Author(s):
YU Yan-ting WANG Xiao-Jian ZHANG Tian-Yan LIU Wei GAO Zhan-Hui LIU Jing JI Da-xi WANG Hong-ying
(Department of Nephrology)
关键词:
动静脉内瘘 终末期肾脏病 远红外线治疗 血液透析
Keywords:
arteriovenous fistula end-stage kidney disease far-infrared therapy hemodialysis
分类号:
R654.3;R318.6
DOI:
10.3969/j.issn.1672-271X.2019.06.010
文献标志码:
A
摘要:
目的 比较远红外线治疗与未治疗对终末期肾脏病患者动静脉内瘘成熟的影响,尤其对老年、糖尿病肾病、高血压肾病患者内瘘血流量的影响。 方法 回顾性分析南京医科大学附属明基医院肾脏科2014年1月1日至2018年7月30日行自体腕部动静脉内瘘成形术患者91例的临床资料,按术后是否行远红外线照射治疗分为对照组45例(未行远红外线照射治疗)和远红外线组46例(术后24 h行远红外线照射治疗),比较2组术后12周内瘘临床成熟率和动静脉内瘘血流量。每组患者再分为不同亚组,根据年龄分为老年(≥60岁)和青中年(<60岁),根据原发病分为糖尿病肾病和非糖尿病肾病,高血压肾病和非高血压肾病,比较远红外线组与对照组不同亚组间12周后内瘘血流量。 结果 远红外线组内瘘临床成熟率高于对照组(97.1% vs 84.3%,P<0.05)。术后12周远红外线组内瘘血流量[(575.9±8.5)mL/min]较对照组[(541.6±75.5)mL/min]明显增加(P<0.01)。远红外线组老年患者、糖尿病肾病患者、高血压肾病患者内瘘血流量[(540.8±50.7)mL/min、(549.3±68.1)mL/min、(565.6±40.3)mL/min]均较对照组[(480.7±51.9)mL/min、(497.3±47.9)mL/min、(505.6±40.3)mL/min]明显增加(P<0.01)。 结论 远红外线治疗能提高终末期肾脏病患者动静脉内瘘临床成熟率,提高术后12周内瘘血流量,尤其对老年、糖尿病肾病、高血压肾病患者内瘘血流量改善明显。
Abstract:
Objective To compare the effects of far-infrared treatment on the maturation of autogenous arteriovenous fistula(AVF)in end-stage renal disease(ESRD), especially on the blood flow of arteriovenous fistula in elderly, diabetic kidney disease(DKD)and hypertensive patients. Methods A retrospective analysis was made on 91 patients who underwent autogenous arteriovenous fistula operation from January 1, 2014 to July 30, 2018 in the Renal Disease Center of BenQ Hospital Affiliated to Nanjing Medical University, including 45 patients who did not receive far-infrared radiation (the control group) and 46 patients who received far-infrared radiation (the far infrared group). The clinical maturity rate and blood flow of AVF were compared 12 weeks after the operation. Each group was divided into elderly (more than 60 years old) and non-elderly (less than 60 years old) according to age. According to the primary disease, each group was divided into DKD and non-DKD, hypertensive nephropathy and non-hypertensive nephropathy. The AVF blood flow of each group was compared after 12 weeks of far infrared treatment. Results The clinical maturity rate of the far infrared group was higher than that of the control group (97.1% vs 84.3%, P<0.05).At 12 weeks after operation, the blood flow of the far infrared group[(575.9 ± 8.5) mL/min] was significantly higher than that of the control group [ (541.6 ± 75.5) mL/min, P<0.01].Compared with the control group, the blood flow of AVF of the elderly patients, DKD patients and hypertensive nephropathy patients in the far infrared Group [(540.8±50.7) mL/min, (549.3±68.1) mL/min, (565.6±40.3) mL/min] significantly increased [(480.7±51.9) mL/min, (497.3±47.9) mL/min, (505.6±40.3) mL/min, P<0.01]. Conclusion Far-infrared treatment can improve the clinical maturity rate of AVF in ESRD and the AVF blood flow in 12 weeks after operation, especially in elderly patients, DKD and hypertensive nephropathy.

参考文献/References:

1 中国医院协会血液净化中心分会血管通路工作组.中国血液透析用血管通路专家共识(第2版)[J].中国血液净化,2019,18(6):365-381.
2 DemberLM, BeckGJ, AllonM, et al. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial[J]. JAMA, 2008, 299(18):2164-2171.
3 BasharK,HealyD,BrowneLD,et al.Role of far infra-red therapy in dialysis arterio-venous fistula maturation and survival: systematic review and meta-analysis[J]. PLos One,2014,9(8):e104931. doi:10.1371/journal.pone.0104931.
4 陈亮亮,吕蓉,刘光军,等.单中心老年肾移植受者临床特征与预后分析[J].中华肾脏病杂志,2015,31(5):321-326.
5 张丽红,王玉柱.北美血管通路协会血液透析血管通路标准化定义解读[J]. 中国血液净化,2013,167-169.
6 余燕婷,高占辉,赵刘兵,等.经皮腔内血管成形术与手术治疗血液透析患者自体动静脉内瘘狭窄的临床效果比较[J]. 医学研究生学报,2017,30(12):1305-1308.
7 LinCC, ChangCF, LaiMY, et al. Far-Infrared Therapy:A Novel Treatment to Improve Access Blood Flow and Unassisted Patency of Arteriovenous Fistula in Hemodialysis Patients[J]. J Am Soc Nephrol, 2007,18(3):985-992.
8 LinCC,YangWC,ChenMC,et al.Effect of far infrared therapy on arteriovenous fistula maturation:an open-label randomized controlled trial[J]. Am J Kidney Dis,2013,62(2):304-311.
9 沈燕,达静静,皮明婧,等.阿托伐他汀联合远红外线照射对动静脉内瘘血栓形成的保护作用[J].中华临床医师杂志,2015,9(17):3175-3179.
10 韩昕彤,马鸿雁,何英,等.扶他林联合远红外线照射治疗动静脉内瘘早期狭窄的效果观察[J].中国血液净化,2014,13(1):62-66.
11 季爱琴,江瑞.糖尿病肾病终末期患者动静脉内瘘远红外线分时段局部照射的效果观察[J].护理学报,2015,22(6):46-47.
12 肖光辉,王玉柱.远红外线照射疗法对自体动静脉内瘘成熟的影响[J].中国血液净化,2014,13(12):845-847.
13 董娟,樊容.对维持性血液透析患者予健康教育的现状及对策[J].东南国防医药,2015,17(6):629-631.
14 潘凌蕴,杜晓凤,朱玲,等.老年慢性肾病患者医院-家庭过渡期用药偏差的发生情况及相关因素分析[J].东南国防医药,2019,21(1):92-94.
15 李倩倩,朱亚梅,刘云,等.维持性血液透析患者的居家血压变异度及影响因素[J].医学研究生学报,2018,31(5):516-520.

相似文献/References:

[1]陈春霞,沈 燕 综述,黄丽璇 审校.动静脉内瘘首次使用护理研究进展[J].医学研究与战创伤救治(原医学研究生学报),2015,17(02):188.[doi:10.3969/j.issn.1672-271X.2015.02.024]
[2]阙立燕,尹岭霞,袁庆霞.动静脉内瘘的护理体会[J].医学研究与战创伤救治(原医学研究生学报),2015,17(03):315.[doi:10.3969/j.issn.1672-271X.2015.03.030]
[3]万小惠,叶君红.人工压力冲击法促进糖尿病肾病患者动静脉内瘘成熟的作用[J].医学研究与战创伤救治(原医学研究生学报),2016,18(02):206.[doi:10.3969/j.issn.1672-271X.2016.02.033]

备注/Memo

备注/Memo:
收稿日期:2019-09-09
更新日期/Last Update: 2019-11-15